The COVID-19 pandemic has changed many aspects of healthcare, notably the rapid rise of telehealth demand and usage by patients, telehealth provision by providers, and temporary and permanent reimbursement changes. However, the quick switch to telehealth usage has brought up questions on how it will impact the larger healthcare system. Are telehealth appointments always appropriate, and if not, when should they be used? How do we incentivize high-value care in telehealth and reduce low-value care? How can we ensure equity in telehealth services?
In this two-part webinar, experts will discuss what we’ve learned from the recent telehealth boon and what we can expect at the state and federal levels, as well as a discussion on ensuring value in telehealth payment and equity in access. The two sessions will be broken down to focus on Equity and Value, respectively.
Dec. 11, 2020
Elaine Khoong, MD, MS, assistant Professor of Medicine at UCSF and general internist at Zuckerberg San Francisco General Hospital
Lee Taylor-Penn, MPA, MPH, Senior Policy Analyst at Families USA
Ian Hill, MPA, MSW, Senior Fellow in the Health Policy Center at the Urban Institute, Project Director of the Strong Start for Mothers and Newborns Evaluation, Project Director of the Best Start LA Pilot Community Evaluation
Dec. 15, 2020
A. Mark Fendrick, MD, Director of the Value-Based Insurance Design (V-BID) Center at the University of Michigan, Professor of Health Management and Policy in the School of Public Health, University of Michigan
Christina Cutter, MD, MSc, MS, IHPI National Clinician Scholar, Clinical Lecturer in the Department of Emergency Medicine, University of Michigan
Nicholas Berlin, MSc, MD, MPH, IHPI National Clinician Scholar, Resident of Plastic Surgery, University of Michigan
Lewis Levy, MD, FACP, Chief Medical Officer at Teladoc
Equity in Telehealth
Value in Telehealth